PL418690A1 - Sposób wykrywania zaburzeń lękowych z napadami lęku - Google Patents

Sposób wykrywania zaburzeń lękowych z napadami lęku

Info

Publication number
PL418690A1
PL418690A1 PL418690A PL41869016A PL418690A1 PL 418690 A1 PL418690 A1 PL 418690A1 PL 418690 A PL418690 A PL 418690A PL 41869016 A PL41869016 A PL 41869016A PL 418690 A1 PL418690 A1 PL 418690A1
Authority
PL
Poland
Prior art keywords
anxiety
detection
attacks
anxiety disorders
patient
Prior art date
Application number
PL418690A
Other languages
English (en)
Inventor
Marcin Jabłoński
Mazur Jolanta Kucharska
Jerzy Samochowiec
Mariusz Ratajczak
Maciej Tarnowski
Barbara Dołęgowska
Original Assignee
Pomorski Univ Medyczny W Szczecinie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pomorski Univ Medyczny W Szczecinie filed Critical Pomorski Univ Medyczny W Szczecinie
Priority to PL418690A priority Critical patent/PL418690A1/pl
Priority to EP17851163.0A priority patent/EP3513199A1/en
Priority to PCT/PL2017/050044 priority patent/WO2018052325A1/en
Publication of PL418690A1 publication Critical patent/PL418690A1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/301—Anxiety or phobic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób wykrywania zaburzeń lękowych z napadami lęku, charakteryzuje się tym, że w próbce biologicznej pobranej od pacjenta bada się osoczowy poziom stężeń składowych kompleksu dopełniacza, sfingozyno 1-fosforanu i stromalnego czynnika wzrostu, przy czym stwierdzenie obniżonego stężenia tych cząsteczek w porównaniu ze średnim stężeniem obserwowanym u osób zdrowych świadczy o wykryciu u tego pacjenta zaburzeń lękowych z napadami leku.
PL418690A 2016-09-14 2016-09-14 Sposób wykrywania zaburzeń lękowych z napadami lęku PL418690A1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL418690A PL418690A1 (pl) 2016-09-14 2016-09-14 Sposób wykrywania zaburzeń lękowych z napadami lęku
EP17851163.0A EP3513199A1 (en) 2016-09-14 2017-09-13 A method for detecting panic disorder
PCT/PL2017/050044 WO2018052325A1 (en) 2016-09-14 2017-09-13 A method for detecting panic disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL418690A PL418690A1 (pl) 2016-09-14 2016-09-14 Sposób wykrywania zaburzeń lękowych z napadami lęku

Publications (1)

Publication Number Publication Date
PL418690A1 true PL418690A1 (pl) 2018-03-26

Family

ID=61619669

Family Applications (1)

Application Number Title Priority Date Filing Date
PL418690A PL418690A1 (pl) 2016-09-14 2016-09-14 Sposób wykrywania zaburzeń lękowych z napadami lęku

Country Status (3)

Country Link
EP (1) EP3513199A1 (pl)
PL (1) PL418690A1 (pl)
WO (1) WO2018052325A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2770734C1 (ru) * 2021-05-31 2022-04-21 Федеральное государственное бюджетное научное учреждение «Томский национальный исследовательский медицинский центр Российской академии наук» (Томский НИМЦ) Способ дифференциальной диагностики панического расстройства и органического тревожного расстройства в связи с сосудистым заболеванием головного мозга

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL223433B1 (pl) * 2013-10-25 2016-10-31 Pomorski Univ Medyczny W Szczecinie Sposób wykrywania pierwszego epizodu psychozy, zwłaszcza o charakterze schizofrenicznym

Also Published As

Publication number Publication date
WO2018052325A1 (en) 2018-03-22
EP3513199A1 (en) 2019-07-24

Similar Documents

Publication Publication Date Title
MX2019007653A (es) Métodos para la optimización de ensayos rápidos de susceptibilidad antimicrobiana.
SG11201702715UA (en) Raman spectroscopy system, apparatus, and method for analyzing, characterizing, and/or diagnosing a type or nature of a sample or a tissue such as an abnormal growth
EP3428644A4 (en) BLOOD DAMPER AND METHOD AND DEVICE FOR TESTING BLOOD THEREWITH
EP3432812A4 (en) SURGICAL INSTRUMENT ASSEMBLY, SET AND SURGICAL SHOULDER REPAIR PROCEDURE
EA201690969A1 (ru) Способы и композиции для лечения связанных со старением состояний
EP3584575A4 (en) INTEGRATED DEVICE FOR FECAL SAMPLING AND OCCULT BLOOD DETECTION
IL253860A0 (en) Devices for the collection and analysis of biological samples and methods for their use
EP3315461A4 (en) MICROPOROUS ELECTRODE AND METHOD FOR THE ANALYSIS OF CHEMICAL SUBSTANCES
EP3442710C0 (en) KITS FOR STORING SAMPLE PROCESSING CONSUMABLES AND SAMPLE PROCESSING INSTRUMENTS
EP3642590C0 (en) ANALYSIS DEVICES AND ANALYSIS APPARATUS FOR USE THEREWITH
EP4343788A3 (en) Diagnostic methods
EP3523639C0 (en) DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR MULTI-ANALYTE DIAGNOSTIC TEST ELEMENTS AND METHODS OF USE THEREOF
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
MX369055B (es) Dispositivo de recogida de fluidos biológicos y sistema de recogida y ensayo de fluidos biológicos.
BR112015022934A2 (pt) esteroides neuroativos, composições, e uso do mesmo
MX360264B (es) Analisis mutacional de adn de plasma para la deteccion de cancer.
PH12015500110A1 (en) Inhibitors of alpha-crystallin aggregation for the treatment of cataract
FR3030048B1 (fr) Procede et dispositif de determination du temps de coagulation d’un echantillon sanguin, et cuvette de reaction
CL2013003433A1 (es) Método para analizar una muestra biológica de un sujeto con cáncer que comprende determinar un nivel de expresión de los biomarcadores gli-1, otx-2, shroom2, pdlim3, y sphk1 en dicha muestra, en donde el nivel de expresión de los biomarcadores en coparación con un control, proporciona un indicador de diagnóstico de si el sujeto tiene una probabilidad aumentada de respuesta a: un ácido metil-4’-trifluorometoxi-bifenil-3-carboxílixo [6-(cis-2,6-dimetil-morfolino-4-il)-piridin-3-il]-amida, ó 2-[(r)-4-(6-bencil-4,5-dimetil-piridazin-3-il)-2-metil-3,4,5,6-tetrahidro-2h-[1,2’] bipirizanil-5’-il]-propan-2-ol; método para seleccionar a un sujeto que tiene cáncer para el tratamiento con uno de dichos compuestos, el cual comprende determinar el nivel de expresión de shroom2 o sphk1, en una muestra biológica del sujeto.
EP3383473A4 (en) BLOOD TEST SYSTEM AND METHOD
EA201790211A1 (ru) Способ прогнозирования результата лечения афлиберцептом пациента, предположительно страдающего от рака
EP3538124A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES, HYPERTENSION AND HYPERCHOLESTEROLEMIA
GB2531213A (en) Systems and methods for high throughput analysis of conformation in biological entities
EP4047089C0 (en) SAMPLE PRESERVATION SOLUTION AND ANALYZER AND ANALYSIS METHOD USING IT
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente